UNIC Athens Pharmacy Insights Series ׀ Drug Regulation in Focus: CNS Products, Bioequivalence, Biowaivers and Emerging Guidelines
UNIC Athens launches the “UNIC Athens Pharmacy Insights Series” with its inaugural event on 20 May 2026. The session, “Drug Regulation in Focus: CNS Products, Bioequivalence, Biowaivers and Emerging Guidelines”, brings together leading experts to discuss key regulatory developments shaping the future of pharmaceutical science, clinical practice, and medicinal product approval.
